Compare Cytokinetics Inc (CYTK) vs Trump Media and Technology Group Corp (DJT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cytokinetics Inc vs Trump Media and Technology Group Corp — how do they compare? Cytokinetics Inc trades at $62.91 (market cap $8.62B), while Trump Media and Technology Group Corp trades at $8.11 (market cap $2.28B). The key difference: Cytokinetics Inc is far larger — about 3.8× Trump Media and Technology Group Corp's market cap, and Cytokinetics Inc is trading nearer its 52-week high, Trump Media and Technology Group Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cytokinetics Inc for 19 Days and Trump Media and Technology Group Corp for 17 Days on average.
| CYTK | DJT | |
|---|---|---|
Market Cap | $8.62B | $2.28B |
Volume | 2,594,626 | 3,148,379 |
Sector | Health | Media |
52-Week High | $87.26 | $17.07 |
52-Week Low | $54.76 | $7.06 |
Typical Hold Time | 19 Days | 17 Days |
Enterprise Value | $8.72B | $2.35B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CYTK trades at $62.01, up 1.46% on the day, with a bearish technical signal from moving averages but oversold RSI readings. The company reported Q2 2026 EPS of -$1.50, beating expectations, but maintains deeply negative profitability with a net income margin of -1,321.12% for 2026. Recent news highlights clinical progress for aficamten in hypertrophic cardiomyopathy studies and presentations at major medical conferences.
Wall Street sentiment is overwhelmingly bullish with a 97.14% buy rating and a $112.60 consensus price target, signaling strong upside potential. However, high cash burn, substantial losses, and significant debt-to-asset ratio of 81.23% present substantial financial risks. Investment appeal hinges on successful commercialization of its pipeline amid intense competition.
DJT trades at $8.20, down 0.24% with a bearish technical signal. The company reported $3.68M revenue for 2025 but a net loss of $712M, reflecting negative margins. Cash flow trends show heavy investing outflows partially funded by financing. Recent news highlights a proposed merger with TAE Technologies and insider selling activity.
Outlook remains challenged by persistent losses and high valuation multiples. The merger with TAE offers strategic diversification but execution risk is high. Investor sentiment is cautious amid weak fundamentals and negative profitability trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →About Trump Media and Technology Group Corp
Trump Media & Technology Group is a media firm rooted in social media and digital streaming. Its flagship product, Truth Social, provides a platform focused on free speech and open conversation.
Read more on DJT →
